Basic Stats
Portfolio Value $ 161,342,907
Current Positions 12
Latest Holdings, Performance, AUM (from 13F, 13D)

Pivotal bioVenture Partners Investment Advisor LLC has disclosed 12 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 161,342,907 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Pivotal bioVenture Partners Investment Advisor LLC’s top holdings are Oculis Holding AG (US:OCS) , Vaxcyte, Inc. (US:PCVX) , Arcutis Biotherapeutics, Inc. (US:ARQT) , Inozyme Pharma, Inc. (US:INZY) , and Zenas BioPharma, Inc. (US:ZBIO) . Pivotal bioVenture Partners Investment Advisor LLC’s new positions include Trevi Therapeutics, Inc. (US:TRVI) , Bolt Biotherapeutics, Inc. (US:BOLT) , .

Pivotal bioVenture Partners Investment Advisor LLC - Portfolio Value
Add This Fund
to your Dashboard
Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)		 Value
(MM$)		 Portfolio % ΔPortfolio %
4.49 17.98 11.1436 7.8333
1.31 42.43 26.2978 4.5781
1.15 6.27 3.8857 3.8857
0.56 4.46 2.7623 1.9547
0.09 0.55 0.3382 0.3382
Top Decreases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)		 Value
(MM$)		 Portfolio % ΔPortfolio %
2.12 29.73 18.4263 -8.4143
2.30 44.66 27.6790 -7.7557
2.40 0.81 0.5038 -0.7612
0.60 3.01 1.8677 -0.6819
0.65 2.70 1.6725 -0.3157
0.78 7.55 4.6788 -0.0310
0.86 1.20 0.7445 -0.0178
13F and Fund Filings

This form was filed on 2025-08-13 for the reporting period 2025-06-30. Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

2022-07-28: Important Note - We have changed the treatment of the Δ Portfolio % column in this table. Previously, we were reporting it as the percent change in the portfolio allocation. We are now reporting it as the raw change in the portfolio allocation (still reported as a percent). In formula terms, we were previously reporting it as 100 * (current allocation - prior allocation ) / prior allocation. We are now reporting it as (current allocation - prior allocation).
Security Type Avg Share Price Shares
(MM)		 ΔShares
(%)		 ΔShares
(%)		 Value
($MM)		 Portfolio
(%)		 ΔPortfolio
(%)
OCS / Oculis Holding AG 2.30 0.00 44.66 2.00 27.6790 -7.7557
PCVX / Vaxcyte, Inc. 1.31 83.63 42.43 58.10 26.2978 4.5781
ARQT / Arcutis Biotherapeutics, Inc. 2.12 0.00 29.73 -10.36 18.4263 -8.4143
INZY / Inozyme Pharma, Inc. 4.49 0.00 17.98 339.58 11.1436 7.8333
ZBIO / Zenas BioPharma, Inc. 0.78 5.76 7.55 29.71 4.6788 -0.0310
TRVI / Trevi Therapeutics, Inc. 1.15 6.27 3.8857 3.8857
VIGL / Vigil Neuroscience, Inc. 0.56 0.00 4.46 346.94 2.7623 1.9547
RXRX / Recursion Pharmaceuticals, Inc. 0.60 0.00 3.01 -4.35 1.8677 -0.6819
BIOA / BioAge Labs, Inc. 0.65 0.00 2.70 9.85 1.6725 -0.3157
IOBT / IO Biotech, Inc. 0.86 0.00 1.20 27.63 0.7445 -0.0178
RLYB / Rallybio Corporation 2.40 0.00 0.81 -48.05 0.5038 -0.7612
BOLT / Bolt Biotherapeutics, Inc. 0.09 0.55 0.3382 0.3382
BOLT / Bolt Biotherapeutics, Inc. 0.00 -100.00 0.00 0.0000